Well, atleast one company sharing the same quarters reported earnings today, and a dividend.....Maybe Cheng should talk to Lin!
Wuyi Pharmaceutical Announces 2010 Annual Results
Recommended Special Dividend of HK8.8 cents per Share
Hong Kong, 28 March, 2011 – Wuyi International Pharmaceutical Company Limited (“Wuyi Pharmaceutical” or the “Group”, HKSE Stock Code: 1889), a vertically integrated specialty pharmaceutical group, today announced its 2010 annual results.
Anyone read this? Only 1 meeting in 2009 of Audit committee:
The Audit Committee, which is established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, engages Company’s independent accountants, reviewing their independence and performance; reviews Company’s financial disclosure, financial statements, and accounting principles, policies, and practices, scope and results of the annual audit, and internal audit and risk management processes and effectiveness of Company’s internal control over financial reporting; reviews related party transactions; and maintains procedures for receipt and handling of reports regarding accounting or financial irregularities. The Audit Committee has a written charter, which appears as Annex I hereto. The Audit Committee held one meeting during 2009.
The members of the Audit Committee are Marco Kung, Chair, George Zhou and Yingshou Huang. The Board has determined that Marco Kung is an audit committee financial expert, as defined in SEC rules.
